NCCN Guidelines® Insights - Adolescent and Young Adult Oncology, Version 1.2014

The NCCN Guidelines Insights on Adolescent and Young Adult (AYA) Oncology discuss the fertility and endocrine issues that are relevant to the management of AYA patients with cancer.  Fertility preservation should be an essential part in the treatment of AYA patients with cancer. The NCCN Guidelines recommend discussion of fertility preservation and contraception prior to the start of treatment. Oophoropexy and embryo cryopreservation are the two established options for fertility preservation in females. Semen cryopreservation before the start of treatment is the most reliable and well established method of preserving fertility in males. AYA women with cancer also have unique contraception needs, depending on the type of cancer, its treatment and treatment-related complications. Management of cancer during pregnancy poses significant diagnostic and therapeutic challenges for both the patient and the physician. AYA women diagnosed with cancer during pregnancy require individualized treatment from a multidisciplinary team involving medical, surgical and radiation oncologists, gynecologic oncologist, obstetricians and perinatologists.

Target Audience

This activity has been designated to meet the educational needs of physicians, nurses, and pharmacists involved in the management of patients with cancer.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Integrate into professional practice the updates to NCCN Guidelines for Adolescent and Young Adult Oncology
  • Describe the rationale behind the decision-making process for developing the NCCN Guidelines for Adolescent and Young Adult Oncology
Additional information
Supporters: 

Supported by an independent educational grant from Prometheus Laboratories Inc., and by an education grant from Exelixis, Inc., and by educational grants from Bayer HealthCare, Onyx Pharmaceuticals, Inc., and Algeta US; Genentech; Genomic Health, Inc.; NOVOCURE; and Merck Sharp & Dohme Corp.

Course summary
Available credit: 
  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician
Course opens: 
01/23/2014
Course expires: 
01/23/2015
Cost:
$0.00

Available Credit

  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

To access this activity, users will need:

  • A device with an Internet connection
  • Adobe Reader or other PDF reader software for article and certificate viewing/printing